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The Authors Reply: We thank Drs Solak and Atalay1 for
their interest in our work.2 With regard to their ﬁrst
comment, we reported data about diabetes, age, and gender,
and adjusted for these factors. More importantly, we adjusted
for phosphorus level—a well-known factor for cardiovascular
morbidity and mortality in dialysis patients.3 Furthermore, we
excluded patients with a failed renal allograft or clotted,
arteriovenous graft in place—two well-known causes of
inﬂammation.4,5 Finally, 47 of 50 patients in the ﬁstula-
catheter group had urine output less than 200ml at the
initiation of dialysis.
With regard to inﬂammatory markers, C-reactive protein
(CRP) is the most commonly assessed marker in dialysis
studies; we had other evidence of inﬂammation (lower
hematocrit and albumin, higher Erythropoiesis Resistance
Index) in catheter patients. In addition, although CRP can
ﬂuctuate, in all cases, the mean (s.d.) CRP levels did not
overlap between ﬁstula and catheter patients at any time
point, suggesting a strong association between CRP and
access. Additional markers, such as IL-6, may provide more
speciﬁcity, but would not have altered the interpretation of
our data. Finally, the last comment is incorrect—all patients
had ﬁstula placement as an elective procedure; catheters were
never placed as a ‘desperate’ attempt, but were used as
vascular access until ﬁstula maturation.
Thus, we believe our data support the role of a non-
infected dialysis catheter as the sole cause of inﬂammation.
1. Solak Y, Atalay H. Non-infected hemodialysis catheters are associated with
increased inflammation compared with arteriovenous fistulas. Kidney Int
2010; 77: 930–931.
2. Goldstein SL, Ikizler TA, Zappitelli M et al. Non-infected hemodialysis
catheters are associated with increased inflammation compared to
arteriovenous fistulas. Kidney Int 2009; 76: 1063–1069.
3. Ayus JC, Mizani MR, Achinger SG et al. Effects of short daily versus
conventional hemodialysis on left ventricular hypertrophy and
inflammatory markers: a prospective, controlled study. J Am Soc Nephrol
2005; 16: 2778–2788.
4. Ayus JC, Sheikh-Hamad D. Silent infection in clotted hemodialysis access
grafts. J Am Soc Nephrol 1998; 9: 1314–1317.
5. Ayus JC, Achinger SG. At the peril of dialysis patients: ignoring the failed
transplant. Semin Dial 2005; 18: 180–184.
Stuart L. Goldstein1 and Juan Carlos Ayus1
1Baylor College of Medicine – Pediatrics, Texas Children’s Hospital, Houston,
Texas, USA
Correspondence: Stuart L. Goldstein, Baylor College of Medicine –Pediatrics,
Texas Children’s Hospital, 6621 Fannin St MC 3-2482, Houston, Texas 77030,
USA. E-mail: slgoldst@TexasChildrensHospital.org
Kidney International (2010) 77, 931; doi:10.1038/ki.2010.57
The CANUSA study and
the importance of residual
kidney function in dialysis
patients
To the Editor: I read with much interest the mini-review by
Rosansky et al.1 that examined the implications of starting
dialysis at a higher glomerular ﬁltration rate (GFR). There
were a couple of inaccurate statements that need to be
corrected for your readers.
The authors describe the Canada –USA Peritoneal Dialysis
Study Group study as ‘an observational study that suggested a
potential beneﬁt on renal survival of a weekly peritoneal
creatinine clearance of 470 l/1.73m2.’ The beneﬁt of that
clearance value was for survival of the patient, not for renal
survival.
In the same paragraph is the following: ‘In addition,
although the Canada – USA Peritoneal Dialysis Study Group
study supported a relationship between the level of peritoneal
clearance and survival, one can argue that the RKF in these
continuous ambulatory peritoneal dialysis patients was
primarily responsible for the survival advantage.’ One could
indeed argue this, and it was exactly this ﬁnding that was
reported in the re-analysis of the Canada – USA Peritoneal
Dialysis Study Group study.2 In this re-analysis, the small
solute clearance parameters were subdivided into the
peritoneal and renal contribution. The peritoneal clearance
had no predictive power on patient survival, whereas every
5 l/week of residual GFR was associated with a 12% reduction
in mortality. Urine volume was an even more powerful
predictor of outcome, with every 250ml/day associated with a
36% reduction in mortality.2
We need to avoid becoming so obsessed with small solute
kinetics that we forget about the importance of residual
kidney function in our dialysis patients.
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The Authors Reply: We strongly agree with Dr Bargman’s1
reference to the importance of residual kidney function in the
decision to start dialysis. In fact, the assumptions used to
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change the National Kidney Foundation guidelines recom-
mending early start (estimated glomerular ﬁltration rate over
10ml/min per m2) fail to consider the fact that dialyzer
clearances have not been shown to relate to patient survival in
two randomized controlled trials.2 Indeed it is illogical to
think that small-molecule dialyzer clearance provides a more
signiﬁcant beneﬁt than a patient’s own residual renal function,
which provides middle molecular as well as other kidney-
speciﬁc beneﬁts. Early dialysis leads to loss of this important
predictor of survival and is another reason why we caution
the nephrology community to examine the wisdom of the
trend to start dialysis early.
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The Authors Reply: We read with interest the report
‘Milky ascites is not always chylous’,1 in which the authors
attribute milky ascites in a patient with calciﬁed sclerosing
peritonitis to massive intraperitoneal amounts of calcium-
hydroxyphosphate–apatite crystals and colloidal calcium-
phosphate–fetuin-A complexes (calciprotein particles). We
have some questions, as this is at most a seldom presentation
of encapsulating peritoneal sclerosis (EPS).2,3 First, the
authors mention that the patient’s peritoneal permeability
was suggestive of sclerosing peritonitis. Although this does
not seem unlikely given both a long-term exposure to
peritoneal dialysis (PD) and the peritoneal calciﬁcations, a
diagnosis of EPS relies on clinical and radiological grounds:
bouts of recurrent, intermittent, or persisting episodes of
intestinal obstructions2,3 with, on computed tomography
scan, the presence of peritoneal thickening and calciﬁcations,
bowel wall thickening, tethering and bowel dilations, and
intra-abdominal ﬂuid loculations.4 Did this patient have
clinical or radiological evidence of EPS? Second, more data
on ascites volume, density, and concentration of other
constituents (creatinine, protein, etc.) could determine
whether the patient is having compartmentalized ascites
(‘loculation’), with no exchanges across the peritoneal
membrane, or ‘dynamic’ recently generated ascites. The
former, but not the latter, might explain the markedly
elevated concentrations of calciprotein particles. Finally,
it would have been of interest to test in vitro, in a test tube,
the apparition of a similar ‘milky’ coloration by mixing
huge amounts of calciprotein particles with a PD used
efﬂuent.
Given the increasing incidence of EPS,2,3 more data from
the present case might help clinicians to recognize this
complication.
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Tunnelled dialysis catheter
tip migration in obese and
large-breasted individuals:
an alternative tunnelling
technique as partial solution
to the problem
To the Editor: In his article, Karam1 describes the case of an
obese woman with cephalad migration of the tunneled
catheter tip, due to the movements of her large breast. We
have observed four similar cases, with repeated catheter
migration despite different tunnel sites, or suture of the
Dacron cuff to the subcutaneous tissue. An alternative
solution has proven efﬁcacious in preventing catheter
migration, using a double catheter with separate channeliza-
tion of its two external extremities (marked as c and d in
Figure 1). The surgical technique differs, as a short skin
incision (b) allows the intermediate exit of the twin catheters,
using the manufacturer’s tunneler; a second tunneler allows
for two separate exit sites. In this way, the reversed-Y
morphology provides stable catheter ﬁxation, precluding its
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